| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.63e-12 | 37 | 80 | 8 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.06e-12 | 38 | 80 | 8 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 9.98e-06 | 11 | 80 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.18e-05 | 14 | 80 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | structural molecule activity | ERVK-6 HSPG2 NUP85 VWA5A ASPH ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 MUC4 | 5.02e-05 | 891 | 80 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 ADAM20 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 | 5.50e-05 | 430 | 80 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 7.82e-05 | 21 | 80 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ADAM20 USP24 ERVK-8 ERVK-18 ERVK-19 ERVK-7 ERVK-21 ERVK-25 ERVK-9 | 2.77e-04 | 654 | 80 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 4.36e-04 | 37 | 80 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 4.72e-04 | 38 | 80 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 7.82e-04 | 103 | 80 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 8.30e-04 | 46 | 80 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | ATP-dependent diacylglycerol kinase activity | 8.52e-04 | 11 | 80 | 2 | GO:0004143 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.03e-03 | 287 | 80 | 6 | GO:0016791 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | PTPN5 ERVK-6 IMPA2 INPP5B ACP3 ERVK-8 PTPN22 ERVK-7 UBASH3B CNOT1 | 1.40e-03 | 807 | 80 | 10 | GO:0016788 |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.18e-03 | 136 | 80 | 4 | GO:0004540 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 2.26e-03 | 65 | 80 | 3 | GO:0016706 | |
| GeneOntologyMolecularFunction | transition metal ion binding | ERVK-6 ASAH2 ERVK-8 CP ERVK-19 ERVK-7 ERVK-21 ERVK-9 ZNF91 PHF8 FTO CA5B | 2.65e-03 | 1189 | 80 | 12 | GO:0046914 |
| GeneOntologyMolecularFunction | inositol phosphate phosphatase activity | 2.87e-03 | 20 | 80 | 2 | GO:0052745 | |
| GeneOntologyMolecularFunction | zinc ion binding | ERVK-6 ASAH2 ERVK-8 ERVK-19 ERVK-7 ERVK-21 ERVK-9 ZNF91 PHF8 CA5B | 2.89e-03 | 891 | 80 | 10 | GO:0008270 |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 3.93e-03 | 79 | 80 | 3 | GO:0004521 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 4.53e-03 | 386 | 80 | 6 | GO:0042578 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.56e-05 | 13 | 80 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.99e-05 | 85 | 80 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.99e-05 | 85 | 80 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 2.49e-05 | 89 | 80 | 5 | GO:0006949 | |
| Domain | DAGK_acc | 6.29e-04 | 10 | 71 | 2 | PF00609 | |
| Domain | Diacylglycerol_kin_accessory | 6.29e-04 | 10 | 71 | 2 | IPR000756 | |
| Domain | DAGKa | 6.29e-04 | 10 | 71 | 2 | SM00045 | |
| Domain | DAGKc | 1.26e-03 | 14 | 71 | 2 | SM00046 | |
| Domain | Diacylglycerol_kinase_cat_dom | 1.45e-03 | 15 | 71 | 2 | IPR001206 | |
| Domain | DAGK_cat | 1.45e-03 | 15 | 71 | 2 | PF00781 | |
| Domain | DAGK | 1.45e-03 | 15 | 71 | 2 | PS50146 | |
| Domain | NAD/diacylglycerol_kinase | 1.87e-03 | 17 | 71 | 2 | IPR016064 | |
| Domain | His_PPase_superfam | 2.59e-03 | 20 | 71 | 2 | IPR029033 | |
| Domain | - | 2.59e-03 | 20 | 71 | 2 | 3.40.50.1240 | |
| Domain | EGF_1 | 2.85e-03 | 255 | 71 | 5 | PS00022 | |
| Domain | Cupredoxin | 3.13e-03 | 22 | 71 | 2 | IPR008972 | |
| Domain | - | 3.59e-03 | 663 | 71 | 8 | 2.60.40.10 | |
| Domain | - | 3.63e-03 | 81 | 71 | 3 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 4.59e-03 | 88 | 71 | 3 | IPR029044 | |
| Domain | Ig-like_fold | 5.23e-03 | 706 | 71 | 8 | IPR013783 | |
| Domain | EGF_LAM_2 | 5.79e-03 | 30 | 71 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 5.79e-03 | 30 | 71 | 2 | PS01248 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 6.44e-14 | 5 | 82 | 5 | 12629516 | |
| Pubmed | 5.03e-11 | 12 | 82 | 5 | 14557543 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.35e-11 | 94 | 82 | 8 | 21542922 | |
| Pubmed | 1.26e-08 | 3 | 82 | 3 | 10516026 | ||
| Pubmed | 8.56e-08 | 18 | 82 | 4 | 18664271 | ||
| Pubmed | 2.51e-07 | 6 | 82 | 3 | 15063128 | ||
| Pubmed | 1.50e-06 | 10 | 82 | 3 | 12970426 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 5.49e-06 | 2 | 82 | 2 | 9460924 | |
| Pubmed | Protein tyrosine phosphatase PTPN22 regulates LFA-1 dependent Th1 responses. | 5.49e-06 | 2 | 82 | 2 | 30054208 | |
| Pubmed | Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. | 5.49e-06 | 2 | 82 | 2 | 11672541 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 9971820 | ||
| Pubmed | Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL. | 3.28e-05 | 4 | 82 | 2 | 23160181 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 3.28e-05 | 4 | 82 | 2 | 10469592 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 7983737 | ||
| Pubmed | Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. | 3.28e-05 | 4 | 82 | 2 | 15894621 | |
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 5.47e-05 | 5 | 82 | 2 | 11401426 | |
| Pubmed | Genome-wide association study of primary dentition pit-and-fissure and smooth surface caries. | 1.09e-04 | 39 | 82 | 3 | 24556642 | |
| Pubmed | Discovery and refinement of loci associated with lipid levels. | 1.46e-04 | 211 | 82 | 5 | 24097068 | |
| Pubmed | 1.96e-04 | 9 | 82 | 2 | 19833889 | ||
| Pubmed | 2.04e-04 | 122 | 82 | 4 | 30773093 | ||
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 21293032 | ||
| Pubmed | 2.98e-04 | 11 | 82 | 2 | 17021016 | ||
| Pubmed | 8.20e-04 | 18 | 82 | 2 | 23726366 | ||
| Pubmed | 1.12e-03 | 21 | 82 | 2 | 30110642 | ||
| Pubmed | Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. | 1.23e-03 | 22 | 82 | 2 | 20694011 | |
| Pubmed | 1.23e-03 | 22 | 82 | 2 | 26589352 | ||
| Pubmed | 1.35e-03 | 23 | 82 | 2 | 30814516 | ||
| Pubmed | 1.59e-03 | 529 | 82 | 6 | 14621295 | ||
| Pubmed | 1.65e-03 | 533 | 82 | 6 | 25544563 | ||
| Pubmed | Perlecan regulates pericyte dynamics in the maintenance and repair of the blood-brain barrier. | 1.86e-03 | 27 | 82 | 2 | 31541017 | |
| Pubmed | Functional genomics identifies therapeutic targets for MYC-driven cancer. | 1.89e-03 | 103 | 82 | 3 | 22623531 | |
| Pubmed | Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration. | 2.01e-03 | 225 | 82 | 4 | 23341629 | |
| Pubmed | Integrated structural analysis of the human nuclear pore complex scaffold. | 2.29e-03 | 30 | 82 | 2 | 24315095 | |
| Pubmed | 2.29e-03 | 30 | 82 | 2 | 27016207 | ||
| Cytoband | 11q24.1 | 1.97e-03 | 37 | 81 | 2 | 11q24.1 | |
| GeneFamily | EF-hand domain containing|Diacylglycerol kinases | 3.19e-04 | 10 | 49 | 2 | 1178 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.07e-03 | 18 | 49 | 2 | 812 | |
| GeneFamily | Phosphoinositide phosphatases | 3.39e-03 | 32 | 49 | 2 | 1079 | |
| GeneFamily | Nucleoporins | 3.39e-03 | 32 | 49 | 2 | 1051 | |
| GeneFamily | Fibronectin type III domain containing | 9.30e-03 | 160 | 49 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.46e-03 | 161 | 49 | 3 | 593 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 7.42e-07 | 189 | 74 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D175|Adult / Lineage, Cell type, age group and donor | 5.16e-06 | 150 | 74 | 5 | b0b6ba3686d3eb8a9b249d30be14111de3b893be | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 184 | 74 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-T_cells-LTi-like_NCR+_ILC3|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.50e-05 | 187 | 74 | 5 | 42b20d7f0a4f9195b3d71dc0e089b5e0914ebcbb | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.58e-05 | 189 | 74 | 5 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-05 | 192 | 74 | 5 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-05 | 195 | 74 | 5 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.93e-05 | 197 | 74 | 5 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.93e-05 | 197 | 74 | 5 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory_LYPD2|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.98e-05 | 198 | 74 | 5 | 4a481e1edb80b950c823ed926842cd5132cfb27f | |
| ToppCell | (06)_OLFM4+|World / shred by cell type by condition | 2.02e-05 | 199 | 74 | 5 | c773b9180dbfec9c19d4098dd43332e6f6050372 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.07e-05 | 200 | 74 | 5 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-05 | 200 | 74 | 5 | 89eae23195d57f1b23a337ff19c9b8a367e22c96 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-05 | 200 | 74 | 5 | fa99901388eec28004bef85d84f0d7d5bd4df4a8 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.95e-05 | 132 | 74 | 4 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.32e-04 | 156 | 74 | 4 | bb505f639dbcad2b788db62d6084c2cb4e884bec | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cyp26b1_(SNc/VTA)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 61 | 74 | 3 | b3f34ed4433aa8a8a9dea9e47fb98620b4e80a6c | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Cyp26b1_(SNc/VTA)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.44e-04 | 61 | 74 | 3 | f41f1e770a5672f32cc5ccec3e33902c40f3fb1b | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 164 | 74 | 4 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 165 | 74 | 4 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.64e-04 | 165 | 74 | 4 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.68e-04 | 166 | 74 | 4 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Outer_Medullary_Collecting_Duct_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.80e-04 | 169 | 74 | 4 | 2a21f2cef959526bfe3c8f081f4f7e9dd4e01a37 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 173 | 74 | 4 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-04 | 173 | 74 | 4 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 174 | 74 | 4 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.01e-04 | 174 | 74 | 4 | 61aa89b56ebda0eba1ba675d5f036992967f670f | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 175 | 74 | 4 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 175 | 74 | 4 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 175 | 74 | 4 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-04 | 175 | 74 | 4 | 98cb577df466700e72d1bbc6689205ccf2e7fcba | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.10e-04 | 176 | 74 | 4 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-04 | 178 | 74 | 4 | d3cbdec9d75f076e565baca05ede292cca7758a4 | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-04 | 178 | 74 | 4 | 7905621f5b2aa55324c5592d1d2fef763a5fa41f | |
| ToppCell | LPS-IL1RA+antiTNF-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-04 | 178 | 74 | 4 | f914092c20130207193f97c6044ae61a9a440a86 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 179 | 74 | 4 | de3ddc1264e43727be50d69b81cc84a3c91812a2 | |
| ToppCell | LPS_only-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.24e-04 | 179 | 74 | 4 | def981e97e3ff9019910c9af3861ca0d08eb0d0f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 179 | 74 | 4 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.34e-04 | 181 | 74 | 4 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-04 | 182 | 74 | 4 | e97681a4102f3095d5d9e90ad70f1dc46e90983a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-04 | 184 | 74 | 4 | 688428103e8b19f45f2f65d70a0f30c904c8411c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 2.54e-04 | 185 | 74 | 4 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.54e-04 | 185 | 74 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | COVID-19-Epithelial_cells-Airway_club|COVID-19 / group, cell type (main and fine annotations) | 2.54e-04 | 185 | 74 | 4 | cfe6fd73d817e173fe803bc1683c291d9bcb8608 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-04 | 185 | 74 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.60e-04 | 186 | 74 | 4 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-04 | 187 | 74 | 4 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 188 | 74 | 4 | 72a1ee136d77c77e44793a512f60b5f7815a073a | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-04 | 188 | 74 | 4 | ecbba19eebba21b986caa99de78ea4245fde3600 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.70e-04 | 188 | 74 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.76e-04 | 189 | 74 | 4 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 2.81e-04 | 190 | 74 | 4 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 190 | 74 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 190 | 74 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.81e-04 | 190 | 74 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.87e-04 | 191 | 74 | 4 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 192 | 74 | 4 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 2.93e-04 | 192 | 74 | 4 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.93e-04 | 192 | 74 | 4 | 0afb9dbe468e0be442c326e11c5fc0f699b32f23 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.93e-04 | 192 | 74 | 4 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 2.99e-04 | 193 | 74 | 4 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.05e-04 | 194 | 74 | 4 | e237384b02be460d44eeada3026a5691c66f6fc1 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.05e-04 | 194 | 74 | 4 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | nucseq-Immune-Immune_Myeloid-pMON|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.05e-04 | 194 | 74 | 4 | 0bc83ae79873a5e473e6e1e3111924cd003986a1 | |
| ToppCell | distal-3-Hematologic-Plasma|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.05e-04 | 194 | 74 | 4 | d6e2e17732ad75604525fd65b2a3171e86cd01c7 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 3.05e-04 | 194 | 74 | 4 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | distal-Epithelial-Differentiating_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.11e-04 | 195 | 74 | 4 | 3fe6e49a9161fc9e5160251e6932cb5378175a54 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 3.11e-04 | 195 | 74 | 4 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 3.11e-04 | 195 | 74 | 4 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | (05)_Secretory|World / shred by cell type by condition | 3.17e-04 | 196 | 74 | 4 | 8032c25b51ef96aeba28cc52686a2bd45213453d | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.17e-04 | 196 | 74 | 4 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | Control-Myeloid-DC2|Control / Condition, Lineage and Cell class | 3.17e-04 | 196 | 74 | 4 | 0ccc26c2811e4c8631e0abd8555b167ac1e7a982 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 3.17e-04 | 196 | 74 | 4 | c9e7ac34993c873de4f198cdae77dcf099731532 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.23e-04 | 197 | 74 | 4 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.23e-04 | 197 | 74 | 4 | 1485933986921ff45669d9b7501c8d17050b3e97 | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.23e-04 | 197 | 74 | 4 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-04 | 197 | 74 | 4 | b8f62fcd6eb8f47b3cc41f616126f82c68a36e87 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.23e-04 | 197 | 74 | 4 | 1638959d7aecb9fc5285eb7e4a3103ca437989e2 | |
| ToppCell | (3)_Chondrocytes-(30)_Chondro|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.23e-04 | 197 | 74 | 4 | a07ab2564ca7d577fd47f444dd7b0c25556e9fc4 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.23e-04 | 197 | 74 | 4 | f870a26f322668781e3d2832c5d9ef2c7c91011f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | d087e738d69ca9853553fde46d4e7a8906439d32 | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.29e-04 | 198 | 74 | 4 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.29e-04 | 198 | 74 | 4 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | 6b6572deeca98ccb015f2aa3c5ce27de44445f74 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 3.29e-04 | 198 | 74 | 4 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.29e-04 | 198 | 74 | 4 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 3.35e-04 | 199 | 74 | 4 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Club|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.35e-04 | 199 | 74 | 4 | 2b357cc08c425a58d45aa6c086101c8fff53e218 | |
| ToppCell | critical-Epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.35e-04 | 199 | 74 | 4 | bbb44e2a52f102a6d891ead6c06d6c07221abd33 | |
| ToppCell | proximal-Epithelial-Differentiating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.35e-04 | 199 | 74 | 4 | c607346f60e5997e757e5a31cab412ab3734377b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 3.35e-04 | 199 | 74 | 4 | 0447f8f53389fe7c6ddc04a97d86e74122ea16f4 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-04 | 199 | 74 | 4 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-04 | 199 | 74 | 4 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | NS-critical-d_07-13-Epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-04 | 199 | 74 | 4 | b88a81cd2a89f4d27100c96ae4324dcee68daf83 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass | 3.35e-04 | 199 | 74 | 4 | 28ec59e01061287fb0892491790b316e2b93e232 | |
| ToppCell | (04)_Interm._basal>secr.|World / shred by cell type by condition | 3.35e-04 | 199 | 74 | 4 | ed399244433f781fc291a9bff16825b8a3ca294f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.35e-04 | 199 | 74 | 4 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | proximal-3-Epithelial-Differentiating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.35e-04 | 199 | 74 | 4 | 12e07084fc2d5d4c418df564ccc0e132b056e549 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 5.36e-04 | 62 | 75 | 3 | EFO_0004616, EFO_1000786 | |
| Disease | smooth surface dental caries | 5.36e-04 | 62 | 75 | 3 | EFO_0006339 | |
| Disease | macular telangiectasia type 2 | 1.99e-03 | 26 | 75 | 2 | EFO_1002009 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QLHTTWEEGLVLPLA | 216 | Q7L8C5 | |
| LHWLLVEDAEGPTPL | 106 | O94766 | |
| RALHPLWESVDLVPG | 46 | Q9Y2D0 | |
| PWEASPSIHILTEIL | 331 | O42043 | |
| VSGPEHPELWRLTVA | 331 | O71037 | |
| VSGPEHPELWRLTVA | 331 | Q902F8 | |
| PWEASPSIHILTEVL | 441 | Q9UKH3 | |
| PATLHPIWGSLGLEE | 981 | A0A096LP49 | |
| HPLEVDVILTGIDIW | 246 | O43506 | |
| ALVVLSWPHVLELLP | 261 | Q6ZMN8 | |
| PIAVVASGIWELHPR | 501 | Q53GS7 | |
| LIFIVDVWHPELTPQ | 736 | Q12797 | |
| LVVLEWEHSEPPIGV | 1046 | O14525 | |
| PLPWQHRLEGDTLII | 3251 | P98160 | |
| TFELEHLPGLPIWIR | 906 | P25092 | |
| HDVPSSIDPILELIW | 196 | Q9Y2R2 | |
| VLVTTLVWHLLRTPP | 156 | P54829 | |
| PEEEHLGILGPVIWA | 441 | P00450 | |
| SLGPVTVQWLLEPHD | 4746 | Q99102 | |
| WIPSLLTLDTLTHPG | 81 | Q8WY50 | |
| THSPLQIVPSLPEWE | 526 | O60732 | |
| ISWDIETPGLAIPLH | 276 | Q9C0B1 | |
| PWHPDIVDVQIITLG | 516 | Q9NR71 | |
| LPEPAGHTVLWIFSL | 16 | P25089 | |
| EPPLVQPLHFLTWDT | 71 | O14576 | |
| WVERLDVTLGPVPEI | 66 | Q99848 | |
| VAPAGPLLLHLLDWV | 156 | Q9BW27 | |
| IPGLESAHVWISIPF | 26 | A6NGY5 | |
| QAVLPPELWIHLAVV | 101 | A0PJZ3 | |
| VAPESHWPELRVLIL | 186 | P53602 | |
| LAERWSLPEIVGIPH | 196 | Q96QE4 | |
| VVLHLEEVTWEPTPS | 131 | P03971 | |
| VGDTAPLPWHIRIGI | 256 | Q9Y616 | |
| LEQHGLPWAIISIPV | 156 | Q9BSG0 | |
| ILITHGPPLGFLDWV | 241 | O15442 | |
| IHPLLGQHWETTVPL | 571 | Q8NDA8 | |
| VLTHSPTWIIDPIDG | 91 | O14732 | |
| VSGPEHPELWRLTVA | 1091 | P63135 | |
| IIWGVGSNSLHLPVP | 361 | O43283 | |
| LLWQPIPVHTVPLSE | 136 | P15309 | |
| GLVVPIIGDFWLHSP | 56 | Q8NG75 | |
| LELVEPSGWIHVPLT | 111 | Q9UM13 | |
| IGPPALVSETLAWEI | 331 | Q8WWV6 | |
| ETPVGFTWIPLLQHG | 651 | Q96HP0 | |
| VSGPEHPELWRLTVA | 331 | P61570 | |
| VSGPEHPELWRLTVA | 331 | Q69384 | |
| HVTPQPEDSWIPLLI | 326 | O95273 | |
| LGAHAAVIVPPTWII | 311 | O75912 | |
| WTLPVLPELDDLTVG | 151 | Q15392 | |
| PEGLFWLLVTGHIPT | 116 | O75390 | |
| EVLEPEHELPLSLWG | 1521 | Q8N3K9 | |
| PWEASPSIHILTEVL | 441 | P61565 | |
| EPQELTTPTLLLWGE | 291 | Q9H6B9 | |
| SEEPWTVLPEHLILV | 2126 | Q8TEP8 | |
| GHPVPFSGLIWVVLT | 296 | Q8IYX4 | |
| LPPLTISNHDVILWL | 511 | P32019 | |
| VSGPEHPELWRLTVA | 331 | Q902F9 | |
| SLGVHAAVVIPPTWI | 231 | Q13574 | |
| HLWPSLEALDPGSLV | 236 | Q6UY18 | |
| LVPILGWPDEVLQAH | 311 | A6NKG5 | |
| PEGVWVTPRHIIINS | 3681 | O75445 | |
| PHSIPLTEVIGPIWL | 161 | Q8N3S3 | |
| PIHITLDSEVVWPAP | 236 | Q8TBZ9 | |
| TVWVPKLPLHIELSD | 531 | Q6IEE7 | |
| GSHLPDLTVITPVFW | 826 | O14841 | |
| PLPDTATGLDWTHLV | 1566 | Q9P2F8 | |
| PPILRPSLHSETWEI | 751 | P20701 | |
| RWPETAVPLTVIDGH | 461 | Q92935 | |
| RPHPWGLLITFIELI | 2316 | A5YKK6 | |
| EILLHPWFESVLEPG | 331 | Q96RU8 | |
| LPEALERWPVHLLET | 381 | P11217 | |
| WVCALGVVPDHPVLL | 1586 | Q7Z4S6 | |
| PTHDLPLILAVDWIV | 441 | P43007 | |
| GEWPTQLDVPHVITL | 21 | Q06203 | |
| VEDVSLSWHLPPGLS | 466 | O00534 | |
| GILDLHGVPVPVTWT | 2286 | Q86WI1 | |
| HTITPVIPLLWEAEA | 1156 | Q05481 | |
| VLDVLWELAHLPTLP | 551 | Q9UPU5 | |
| TLFIPTGWIHAVLTP | 346 | Q9UPP1 | |
| IWQLTDPPILPLTHG | 621 | Q8TF42 | |
| LDETVLWVVHVSGPI | 281 | Q8IYS2 | |
| PEDLIWHTPEGISIK | 56 | P22033 | |
| LAGPIIVEPHVTAVW | 56 | Q9NQS3 |